Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 13/20 | 0.64 |
| ▸ | IL1RN | P18510 | 12/20 | 0.64 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.60 |
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.55 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL644843 | 0.90 | MEN1 (0.62) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL31483276 | 0.90 | ERAP2 (0.69) | ERAP2MEN1KMT2A | |
| SCHEMBL29350328 | 0.89 | ERAP2 (0.65) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL29531509 | 0.88 | ERAP2 (0.65) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL30567418 | 0.88 | ERAP2 (0.65) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL31215422 | 0.88 | ERAP2 (0.64) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL17534499 | 0.88 | MEN1 (0.61) | ERAP2IL1RNERAP1MEN1KMT2A | |
| SCHEMBL17534495 | 0.88 | MEN1 (0.61) | ERAP2IL1RNERAP1MEN1KMT2A | |
| Oglufanide SCHEMBL24454642 | 0.88 | ERAP2 (0.68) | ERAP2MEN1KMT2A | |
| Oglufanide SCHEMBL1898073 | 0.88 | ERAP2 (0.68) | ERAP2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024041532-A1 | TETRAVALENT PLATINUM-CONTAINING COMPLEX, PRODRUG, PREPARATION METHOD THEREFOR, AND USE THEREOF | 赣州和美药业股份有限公司 | 2024-02-29 | — | — | WO | disclosed |
| CN-117603299-A | Tetravalent platinum-containing complex, prodrug, preparation method and application thereof | 赣州和美药业股份有限公司 | 2024-02-27 | — | — | CN | disclosed |